Comment on “α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation”

Haiping Hao

doi:10.1016/j.jpha.2026.101574

Volume 16 Issue 1

Jan. 2026

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2026 > 16(1): 101574

Haiping Hao. Comment on “α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation”[J]. Journal of Pharmaceutical Analysis, 2026, 16(1): 101574. doi: 10.1016/j.jpha.2026.101574

Citation:

Haiping Hao. Comment on “α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation”[J]. Journal of Pharmaceutical Analysis, 2026, 16(1): 101574. doi: 10.1016/j.jpha.2026.101574

Citation:

PDF( 0 KB)

Comment on “α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation”

doi: 10.1016/j.jpha.2026.101574

Haiping Hao

State Key Laboratory of Natural Medicines, Laboratory of Metabolic Regulation and Drug Target Discovery, China Pharmaceutical University, Nanjing, 210009, China

Publish Date: Feb. 16, 2026

Abstract

FullText(HTML)

References(5)

References

[1]	S. Zhang, Z. Yang, W. Bao, et al., SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC, Autophagy 16 (2020) 735-749.
[2]	S. Solanki, K. Sanchez, V. Ponnusamy, et al., Dysregulated amino acid sensing drives colorectal cancer growth and metabolic reprogramming leading to chemoresistance, Gastroenterology 164 (2023) 376-391.e13.
[3]	D. Meng, M. Ren, M. Li, et al., Molecular mechanism of α-Hederin in tumor progression, Biomed. Pharmacother. 170 (2024), 116097.
[4]	H. Feng, J. Tan, Q. Wang, et al., α-hederin regulates glucose metabolism in intestinal epithelial cells by increasing SNX10 expression, Phytomedicine 111 (2023), 154677.
[5]	H. Feng, J. Wang, L. Tao, et al., α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation, J. Pharm. Anal. 15 (2025), 101301.